Navigation Links
Nile Therapeutics Receives Fast Track Designation for Cenderitide for Post-Acute Indication
Date:3/31/2011

review the NDA from ten to six months. Fast Track designation is intended to bring valuable treatments more quickly to patients in need.

About Nile Therapeutics

Nile Therapeutics, Inc. is a biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical needs. Nile is initially focusing its efforts on developing its lead compound, cenderitide, a novel rationally designed chimeric peptide in clinical studies for the treatment of heart failure, and CU-NP, a novel rationally designed natriuretic peptide. More information on Nile can be found at http://www.nilethera.com.

Safe Harbor Paragraph for Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding Nile's plans to develop cenderitide in the post-acute setting, the anticipated benefits of cenderitide for patients in the post-acute setting, and Nile's ability to obtain FDA approval of cenderitide in the post-acute setting, are forward-looking statements. Forward-looking statements also include statements regarding the timing, progress and anticipated results of the clinical development, regulatory processes, clinical trial timelines, expected patient enrollment, anticipated benefits of cenderitide, Nile's strategy, future operations, outlook, milestones, the timing and success of Nile's product development, future financial position, future financial results, plans and objectives of management are forward-looking statements. Nile may not actually achieve these plans, intentions or expectations and Nile cautions investors not to place undue reliance on Nile's forward-looking statements. Actual results or events could di
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. PTC Therapeutics Appoints Robert Spiegel, M.D. as Chief Medical Officer
2. Cara Therapeutics Announces Appointment of James B. Jones, M.D., Pharm.D., as Chief Medical Officer
3. Nile Therapeutics Announces Upcoming Data Presentation at the American College of Cardiology Annual Scientific Meeting
4. Silence Therapeutics Phase I Atu027 Data Accepted for Presentation at the American Society of Clinical Oncology 2011 Annual Meeting
5. Osseon™ Therapeutics Introduces Osseoflex® BT Steerable Bone Tamp
6. Yuma Therapeutics Awarded a Research Grant by the Alzheimers Drug Discovery Foundation to Develop Novel Therapeutics for Alzheimers Disease
7. Mersana Therapeutics Initiates Phase 1b Extension Study of XMT-1001 in Gastric Cancer and Non-Small Cell Lung Cancer
8. Reportlinker Adds Therapeutics for Immune System Disorders
9. Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis
10. Echo Therapeutics Hires Two Seasoned Medical Device and Diagnostics Executives
11. Pervasis Therapeutics Announces Late-Breaking Oral Presentation at American Association for Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 30, 2014   ViaDerma, Inc. (OTCQB: ... new products to market, has recently released a ... is a topical liquid tetracycline-based antibiotic that uses ... convert oral medication active ingredients into topical drugs. ... aid antibiotic to help prevent skin infection in ...
(Date:10/30/2014)... 30, 2014 CVS Health (NYSE: CVS ... with three leading regional health systems to enhance access to ... systems include Baptist Health System in Alabama ... Health in Pennsylvania , Northwest Medical Center, ... and Tennova Healthcare in Tennessee ; and ...
(Date:10/30/2014)... 30, 2014 Molecular Profiles Ltd., a subsidiary ... and Maryland -based Xceleron have announced ... during clinical development that will be launched at AAPS ... This partnership extends Molecular Profiles, new ROADMAP ... earlier this month. The company also has complementary collaborations ...
Breaking Medicine Technology:ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 2CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 3CVS Health Announces New Clinical Affiliations with Leading Regional Health Systems 4Molecular Profiles To Launch US Strategic Alliance At AAPS 2Molecular Profiles To Launch US Strategic Alliance At AAPS 3
... Nordisk Inc., a global healthcare company and leader in diabetes care, today ... information on diabetes and chronic disease, highlighting key issues in diabetes prevention, ... , ... evolved over the last 90 years, how it is developed today, the ...
... NEW ORLEANS , July 12 Proventix Systems, Inc., of ... Alabama -based technology company, that will help them fight the spread ... , , , , ... in Infection Control and Epidemiology, HAIs contribute $28 billion to $33 ...
Cached Medicine Technology:Novo Nordisk Addresses Innovation in Diabetes Care in Second Issue of Industry Resource for Information on Diabetes and Chronic Disease 2Proventix™ Partners with Synapse Wireless to Save Lives 2Proventix™ Partners with Synapse Wireless to Save Lives 3
(Date:10/30/2014)... PreDiabetes Centers , the pioneer in ... with a supply of sugardown®, a chewable dietary supplement ... sugar spikes. Learning how to control blood sugar levels ... a diabetes prevention plan. , Shoppers who spend $50 ... of sugardown. The offer expires November 30. , ...
(Date:10/30/2014)... By Tara Haelle ... (HealthDay News) -- More than 100 genes have been ... new studies report. And researchers say they are ... overall that may contribute to the disorder. Autism ... by communication and social difficulties and repetitive behaviors. An ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 Horse ... therapeutic horseback riding to special needs individuals in the ... on Saturday, November 15 from 10-2:00 p.m. at Bailey's ... is open to the public and is designed to ... , Admission to the HSS Round-Up is free. Ticket ...
(Date:10/30/2014)... Rock Hill, South Carolina (PRWEB) October 30, 2014 ... a muscle, and should be more vigorously exercised to ... Grewal. He recently authored the book ‘Dementia Express: Lose ... , The book uses counterintuitive reasoning and sometimes conflicting ... an obstacle course for the mind, a reader must ...
(Date:10/30/2014)... comes to heart disease, a new study finds women are ... symptoms that spell trouble. "The main danger is that ... or advanced stage of heart disease, there are simply fewer ... and research fellow at the Harvard School of Public Health, ... Foundation of Canada. In the study, researchers talked to ...
Breaking Medicine News(10 mins):Health News:PreDiabetes Treatment Company Offers PreD Store Shoppers Supplements to Support Healthy Blood Sugar 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 3Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2Health News:Women Often Ignore Signs of Heart Trouble 2
... MONICA, Calif., Feb. 3 The most common New ... on,physical appearance: lose weight, tone up, exercise more, and ... finding an intimate relationship,between body and mind. In order ... to maintain mental health and cognitive function as well ...
... 3 The US market for the drug treatment of ... to US Cancer Pain, a report released today by WWMR, ... a trend expected to continue throughout the next decade. ... primary driver of market value during the forecast period. ...
... CDC reports decline in two-thirds of the country, , , TUESDAY, ... decade in nearly two-thirds of the states, according to a ... Prevention. , The CDC,s data analysis showed that mammography use ... including Minnesota, Tennessee, Georgia and Alabama. But it fell by ...
... play a critical role in world,s largest global ... coming months, hundreds of Rotary club members from ... the United Kingdom and the Caribbean will join ... and health workers to immunize children against polio ...
... Breakthrough findings contribute to better understanding of little-known disease ... Feb. 3 A new research study has identified ... primary torsion dystonia (DYT6 type) in Amish-Mennonite families and ... that THAP1 causes dystonia in other ethnic groups.A paper ...
... Texas, Feb. 3 UpSpring Baby (TM) today ... breast milk is now available for purchase over-the-counter at ... is the nation,s largest drugstore chain and the first ... test. Milkscreen is also available for purchase through ...
Cached Medicine News:Health News:Dakim Recommends Six New Year Resolutions to Stay Cognitively Fit 2Health News:US Cancer Pain Market to Reach $5 Billion by 2018 - Cancer Patient Growth Drives Value 2Health News:US Cancer Pain Market to Reach $5 Billion by 2018 - Cancer Patient Growth Drives Value 3Health News:Fewer Women Are Having Mammograms 2Health News:Rotary Members Worldwide Prepare For Mass Immunization Campaigns In Polio-Endemic Countries 2Health News:Rotary Members Worldwide Prepare For Mass Immunization Campaigns In Polio-Endemic Countries 3Health News:The Bachmann-Strauss Dystonia & Parkinson Foundation: New Study Identifies Gene Mutations as Cause of Dystonia in Amish-Mennonite Families 2Health News:Milkscreen Home Test for Alcohol in Breast Milk Begins Nationwide Sales at Walgreens 2
... Dynal RELI™ SSO typing technique utilises a ... flank the specific target region of an ... of the resulting amplicon to an array ... a nylon membrane. The immobilisation of these ...
... The Reichert UNISTAT ... photometric analyzer for determining ... newborn infants. It quickly ... tests are needed by ...
Biotest ELPHA (=Enzyme Linked Probe Hybridization Assay) for class I and class II HLA typing shows convincing advantages for your lab routine....
... Follicle-Stimulating Hormone (FSH) is a glygoprotein produced by ... as LH, TSH, and HCG, FSH consists of ... is a solid phase direct sandwich ELISA method. ... to the wells coated with Mab to FSH ...
Medicine Products: